(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone
Fasoracetam
CAS: 110958-19-5
Molecular Formula: C10H16N2O2
(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone - Names and Identifiers
(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone - Physico-chemical Properties
| Molecular Formula | C10H16N2O2 |
| Molar Mass | 196.25 |
| Density | 1.181±0.06 g/cm3(Predicted) |
| Boling Point | 456.8±38.0 °C(Predicted) |
| pKa | 15.45±0.40(Predicted) |
(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone - Introduction
Fasoracetam(Fasoracetam) is a synthetic intelligent drug, belonging to the class of Racetam compounds. Its chemical name is (R)-over and its molecular formula is C10H16N2O2.
Fasoracetam is considered to have the effect of improving cognitive ability and learning and memory. Studies have shown that it may improve memory and learning ability by regulating the function of the glutamatergic system in the brain and promoting the release of the neurotransmitter glutamate.
In addition, Fasoracetam has been studied for the treatment of attention deficit hyperactivity disorder (ADHD) and anxiety disorders. Preliminary data suggest it may help slow symptoms and improve patients' concentration and emotional state.
In the production method, the Fasoracetam is usually obtained by chemical synthesis. The specific preparation method can be carried out according to the patent literature.
In terms of safety information, the side effects and potential risks of Fasoracetam are unclear, because large-scale studies and long-term safety studies on its clinical use are insufficient. At present, Fasoracetam has not been approved by the US Food and Drug Administration (FDA) for clinical treatment.
Fasoracetam is considered to have the effect of improving cognitive ability and learning and memory. Studies have shown that it may improve memory and learning ability by regulating the function of the glutamatergic system in the brain and promoting the release of the neurotransmitter glutamate.
In addition, Fasoracetam has been studied for the treatment of attention deficit hyperactivity disorder (ADHD) and anxiety disorders. Preliminary data suggest it may help slow symptoms and improve patients' concentration and emotional state.
In the production method, the Fasoracetam is usually obtained by chemical synthesis. The specific preparation method can be carried out according to the patent literature.
In terms of safety information, the side effects and potential risks of Fasoracetam are unclear, because large-scale studies and long-term safety studies on its clinical use are insufficient. At present, Fasoracetam has not been approved by the US Food and Drug Administration (FDA) for clinical treatment.
Last Update：2024-04-09 21:48:26
